Andy
Retired committee member
Full title: Psychiatric characteristics of older persons with Medically Unexplained Symptoms; a comparison with older patients suffering from Medically Explained Symptoms
Open access PDF, https://www.cambridge.org/core/serv...ffering_from_medically_explained_symptoms.pdf
Journal page, https://www.cambridge.org/core/jour...ned-symptoms/9882B332D59AE93AFAD5CE4471598C9FBackground: Empirical studies on the clinical characteristics of older persons with Medically Unexplained Symptoms (MUS) are limited to uncontrolled pilot studies. Therefore, we aim to examine the psychiatric characteristics of older patients with MUS compared to older patients with medically explained symptoms (MES), also across healthcare settings.
Methods: A case-control study including 118 older patients with MUS and 154 older patients with MES. To include patients with various developmental and severity stages, patients with MUS were recruited in the community (n=12), primary care (n=77) and specialized health care (n=29). Psychopathology was assessed according to DSM-IV-TR criteria (Mini International Neuropsychiatric Interview) and by dimensional measures (e.g. psychological distress; hypochondriasis; depressive symptoms).
Results: A total of 69/118 (58.5%) patients with MUS met the criteria for a somatoform disorder according to DSM-IV-TR criteria, with the highest proportion among patients recruited in specialized healthcare settings (p=.008). Patients with MUS had a higher level of psychological distress and hypochondriasis compared to patients with MES. Although psychiatric disorders (beyond somatoform disorders) were more frequently found among patients with MUS compared to patients with MES (42.4% versus 24.8 %, p=.008), this difference disappeared when adjusted for age, sex and level of education (OR=1.7 [95% CI: 48 1.0 – 3.0], p=.070).
Conclusions: Although psychological distress is significantly higher among older patients with MUS compared to those with MES, psychiatric comorbidity rates hardly differ between both patient groups. Therefore, treatment of MUS in later life should primarily focus on reducing psychological distress, irrespective of the healthcare setting patients are treated in.
Open access PDF, https://www.cambridge.org/core/serv...ffering_from_medically_explained_symptoms.pdf
Last edited by a moderator: